Cancer type predicts alloimmunization following RhD-incompatible RBC transfusions

Transfusion

Volumn 57, Issue 4, 2017, Pages 952-958

  Arora, Komal ^a   Kelley, James ^a   Sui, Dawen ^a   Ning, Jing ^a   Martinez, Fernando ^a   Lichtiger, Benjamin ^a   Tholpady, Ashok ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RHESUS D ANTIGEN; BLOOD GROUP RHESUS SYSTEM; RHESUS D ANTIBODY;

ACUTE LEUKEMIA; ADULT; AGED; ALLOIMMUNIZATION; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; BLOOD GROUP ABO SYSTEM; BLOOD GROUP RHESUS SYSTEM; CARCINOMA; ERYTHROCYTE TRANSFUSION; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE NEOPLASM; RETROSPECTIVE STUDY; AGE; BLOOD; CLINICAL TRIAL; INCIDENCE; MIDDLE AGED; NEOPLASMS; RH ISOIMMUNIZATION; SEX DIFFERENCE;

AGE FACTORS; AGED; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; RH ISOIMMUNIZATION; RH-HR BLOOD-GROUP SYSTEM; RHO(D) IMMUNE GLOBULIN; SEX FACTORS;

EID: 85012247162     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13999     Document Type: Article

References (39)

1. Shirey RS, King KE. Alloimmunization to blood group antigens. In: Anderson KC, Ness PM, editors. Scientific basis of transfusion medicine. Implications for clinical practice. Philadelphia, PA: W.B. Saunders; 2000. p. 393-400.
2. Gunson HH, Stratton F, Cooper DG, et al. Primary immunization of Rh-negative volunteers. Br Med J 1970;1:593-5.
3. Urbaniak SJ, Robertson AE. A successful program of immunizing Rh-negative male volunteers for anti-D production using frozen/thawed blood. Transfusion 1981;21:64-9.
4. Cook K, Rush B. D immunization after massive transfusion of D-positive blood. Med J Aust 1974;1:166-8.
5. Schmidt PJ, Leparc GF, Samia CT. Use of Rh positive blood in emergency situations. Surg Gynecol Obstet 1988;167:229-33.
6. Ramsey G, Hahn LF, Cornell FW, et al. Low rate of Rhesus immunization from Rh-incompatible blood transfusions during liver and heart transplant surgery. Transplantation 1989;47:993-5.
7. Casanueva M, Valdes MD, Ribera MC. Lack of alloimmunization to D antigen in D-negative immunosuppressed liver transplant recipients. Transfusion 1994;34:570-2.
8. Frohn C, Dümbgen L, Brand JM, et al. Probability of anti-D development in D-patients receiving D+ RBCs. Transfusion 2003;43:893-8.
9. Boctor FN, Ali NM, Mohandas K, et al. Absence of D-alloimmunization in AIDS patients receiving D-mismatched RBCs. Transfusion 2003;43:173-6.
10. Asfour M, Narvios A, Lichtiger B. Transfusion of RhD-incompatible blood components in RhD-negative blood marrow transplant recipients [database]. MedGenMed 2004;6:22.
11. Yazer MH, Triulzi DJ. Detection of anti-D in D− recipients transfused with D+ red blood cells. Transfusion 2007;47:2197-201.
12. Goldfinger D, McGinniss MH. Rh-incompatible platelet transfusions—risks and consequences of sensitizing immunosuppressed patients. N Engl J Med 1971;284:942-4.
13. Lichtiger B, Surgeon J, Rhorer S. Rh-incompatible platelet transfusion therapy in cancer patients: a study of 30 patients. Vox Sang 1983;45:139-43.
14. Lichtiger B, Hester JP. Transfusion of Rh-incompatible blood components to cancer patients. Haematologia (Budap) 1986;19:81-8.
15. Baldwin ML, Ness PM, Scott D, et al. Alloimmunization to D antigen and HLA in D-negative immunosuppressed oncology patients. Transfusion 1988;28:330-3.
16. McLeod BC, Piehl MR, Sassetti RJ. Alloimmunization to RhD by platelet transfusions in autologous bone marrow transplant recipients. Vox Sang 1990;59:185-9.
17. Heim MU, Böck M, Kolb HJ, et al. Intravenous anti-D gammaglobulin for the prevention of rhesus isoimmunization caused by platelet transfusions in patients with malignant diseases. Vox Sang 1992;62:165-8.
18. Atoyebi W, Mundy N, Croxton T, et al. Is it necessary to administer anti-D to prevent RhD immunization after the transfusion of RhD-positive platelet concentrates? Br J Haematol 2000;111:980-3.
19. Cid J, Ortin X, Elies E, et al. Absence of anti-D alloimmunization in hematologic patients after D-incompatible platelet transfusions. Transfusion 2002;42:173-6.
20. Molnar R, Johnson R, Sweat LT, et al. Absence of D alloimmunization in D-pediatric oncology patients receiving D-incompatible single-donor platelets. Transfusion 2002;42:177-82.
21. Chamouni P, Josset V, Bastit D, et al. Transfusions of rhesus-incompatible platelet concentrates in Rouen University Hospital: procedures and consequences [article in French]. Transfus Clin Biol 2005;12:306-12.
22. Bartley AN, Carpenter JB, Berg MP. D+ platelet transfusions in D-patients: cause for concern? Immunohematology 2009;25:5-8.
23. Cid J, Carbassé G, Pereira A, Sanz C, Mazzara R, Escolar G, Lozano M. Platelet transfusions from D+ donors to D-patients: a 10-year follow-up study of 1014 patients. Transfusion 2011;51:1163-9.
24. Cid J, Lozano M, Ziman A, et al. Low frequency of anti-D alloimmunization following D+ platelet transfusion: the Anti-D Alloimmunization after D-incompatible Platelet Transfusions (ADAPT) study. Br J Haematol 2015;168:598-603.
25. Weinstein R, Simard A, Ferschke J, et al. Prospective surveillance of D− recipients of D+ apheresis platelets: alloimmunization against D is not detected. Transfusion 2015;55:1327-30.
26. Contreras M, Mollison PL. Failure to augment primary Rh immunization using a small dose of “passive” IgG anti-Rh. Br J Haematol 1981;49:371-81.
27. Issitt PD. The Rh blood groups. In: Garratty G, editor. Immunobiology of transfusion medicine. New York: Marcel Dekker; 1994. p. 125.
28. Gunson HH, Stratton F, Phillips PK. The use of modified cells to induce an anti-Rh response. Br J Haematol 1971;21:683-94.
29. Sanz C, Nomdedeu M, Belkaid M, et al. Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia. Transfusion 2013;53:710-5.
30. Novaretti MC1, Sopelete CR, Velloso ER, et al. Immunohematological findings in myelodysplastic syndrome. Acta Haematol 2001;105:1-6.
31. Bauer MP, Wiersum-Osselton J, Schipperus M, et al. Clinical predictors of alloimmunization after red blood cell transfusion. Transfusion 2007;47:2066-71.
32. Verduin EP, Brand A, Schonewille H. Is female sex a risk factor for red blood cell alloimmunization after transfusion? A systematic review. Transfus Med Rev 2012;26:342-53.
33. Ameen R, Al-Shemmari S, Al-Humood S, et al. RBC alloimmunization and autoimmunization among transfusion-dependent Arab thalassemia patients. Transfusion 2003;43:1604-10.
34. Klein HG, Anstee DJ. Immunology of red cells. In: Klein HG, Anstee DJ, editors. Blood transfusion in clinical medicine. 11th ed. Oxford: Blackwell Science Ltd; 2005. p. 48-113.
35. Teesdale P, de Silva M, Contreras M. Development of non-Rh antibodies in volunteers stimulated for the production of hyperimmune anti-D. Vox Sang 1991;61:37-9.
36. Schonewille H, Brand A. Does an alloimmune response to strong immunogenic red blood cell antigens enhance a response to weaker antigens? Transfusion 2008;48:958-63.
37. Narvios AB, Reddy V, Lichtiger B. Method of removing incompatible red blood cells from granulocyte components. Transfus Apher Sci 2006;35:179-80.
38. Martín Ibáñez I, Arce Casas A, Cruz Martínez O, et al. Humoral immunity in pediatric patients with acute lymphoblastic leukaemia. Allergol Immunopathol (Madr) 2003;31:303-10.
39. Solh Z, Athale U, Arnold DM, Cook RJ, Foley R, Heddle NM. Transfusion-related alloimmunization in children: epidemiology and effects of chemotherapy. Vox Sang 2016;111:299-307.